Neuroimaging Biomarkers for Psychosis

Current Behavioral Neuroscience Reports
doi 10.1007/s40473-015-0035-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neuroimaging Biomarkers for Early Drug Development in Schizophrenia

Biological Psychiatry
Biological Psychiatry
2014English

Is Neuroimaging Clinically Useful in Subjects at High Risk for Psychosis?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2016English

Does Neuroimaging Have a Role in Predicting Outcomes in Psychosis?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2017English

Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

American Journal of Psychiatry
PsychiatryMental Health
2016English

Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection

Annual Review of Clinical Psychology
MedicineClinical PsychologyPsychiatryMental Health
2013English

Peripheral Biomarkers for First-Episode Psychosis—Opportunities From the Neuroinflammatory Hypothesis of Schizophrenia

Psychiatry Investigation
PsychiatryMental HealthBiological Psychiatry
2019English

Clinical and Neuroimaging Biomarkers of Amyloid-Negative Logopenic Primary Progressive Aphasia

Brain and Language
LinguisticsLanguageCognitive PsychologyCognitive NeuroscienceHearingSpeechExperimental
2015English

Response to Sarpal Et Al.: Importance of Neuroimaging Biomarkers for Treatment Development and Clinical Practice

American Journal of Psychiatry
PsychiatryMental Health
2016English

Graph Theoretical Analysis of Structural Neuroimaging in Temporal Lobe Epilepsy With and Without Psychosis

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy